CompletedNCT05415540
Evolution of the Quality of Life and Experience of Young Women With Utero-vaginal Aplasia (MRKHPSY)
Studying Mayer-Rokitansky-Küster-Hauser syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Alaa CHEIKHELARD, Doctor
- Intervention
- Questionnaires(other)
- Enrollment
- 25 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2022 – 2024
Study locations (1)
- Necker Children's Hospital, Paris, France
Collaborators
Foundation for Rare Diseases · Necker Imagine Foundation · Laboratory of Clinical Psychology, Psychopathology and Psychoanalysis · URC-CIC Paris Descartes Necker Cochin
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05415540 on ClinicalTrials.govOther trials for Mayer-Rokitansky-Küster-Hauser syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07186764Evaluation of the Quality of Life and Gynecological Follow-up of Patients Treated for Mayer-Rokitansky-Küster-Hauser (MRKH) SyndromeUniversity Hospital, Toulouse
- RECRUITINGNANCT03689842Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)Hopital Foch
See all trials for Mayer-Rokitansky-Küster-Hauser syndrome →